Cell therapy with human reprogrammed cd8+ t-cells has antimetastatic effects on lewis lung carcinoma in c57bl/6 mice

HIGHLIGHTS

• who: Evgenii G. Skurikhin and colleagues from the Laboratory of Regenerative Pharmacology, Goldberg ED Research Institute of Pharmacology and Lenin, , Tomsk, Russia Ministry of Health of the Russian Federation, Siberian State Medical University have published the article: Cell Therapy with Human Reprogrammed CD8+ T-Cells Has Antimetastatic Effects on Lewis Lung Carcinoma in C57BL/6 Mice, in the Journal: (JOURNAL)
• what: Low frequencies of target mutations in the EGFR and 2 of 16 ALK genes in patients with NSCLC is the main reason for the lower response to targeted therapy. The authors assessed antitumor and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.